telogen effluvium semaglutide Hair loss has increasingly been reported among patients using GLP-1 and GIP agonists for weight loss. These include drugs like semaglutide, tirzepatide, liraglutide and others. Historically, this hair loss has been attributed GLP-1 Medications and Hair Loss:

Phase 3 clinical trial results showed that participants lost an average of 15.3 kg

Visceral Fat Loss: High efficacy in targeting "stubborn" belly fat, which is the most metabolically active and dangerous type of fat

Gut Health Support BPC-157 is derived from compounds found in the gut, and its arginate variant is studied for its ability to protect the gastric lining , manage inflammation, and assist in gastrointestinal healing

It is not covered by Medicare but is still cheaper than ordering from Germany

Glutathione: In addition to its ability to inhibit melanin production, glutathione has been used for its skin lightening properties